Pfizer has a total of 66947 patents globally, out of which 20858 have been granted. Of these 66947 patents, more than 29% patents are active. United States of America is where Pfizer has filed the maximum number of patents, followed by Japan and Europe (EPO). Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Pfizer.
Pfizer was founded in the year 1849. The company operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas.
Do read about some of the most popular patents of Pfizer which have been covered by us in this article and also you can find Pfizer patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Pfizer patent portfolio.
Pfizer Innovation Prediction Roadmap: 2025–2030
The insights and projections presented in this article are based on predictive analysis, current patent analysis that have been done, and publicly available information as of 2025. While care has been taken to ensure accuracy, the forward-looking statements are speculative and should not be interpreted as definitive strategic actions by Pfizer or its affiliates. This content is intended for informational and research purposes only and does not constitute legal, financial, or investment advice.
Want to explore which innovation areas Pfizer is likely to focus on next and where its future patent surge could occur? Fill out the form to get the details.
How many patents does Pfizer have?
Pfizer has a total of 66947 patents globally. These patents belong to 11559 unique patent families. Out of 66947 patents, 20316 patents are active.
How Many Patents did Pfizer File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Pfizer Applications Filed | Pfizer Patents Granted |
| 2026 | 34 | 229 |
| 2025 | 460 | 888 |
| 2024 | 710 | 699 |
| 2023 | 1160 | 916 |
| 2022 | 1139 | 867 |
| 2021 | 1762 | 992 |
| 2020 | 1440 | 1071 |
| 2019 | 2001 | 994 |
| 2018 | 2082 | 1012 |
| 2017 | 2191 | 1041 |
Which Pfizer Drug Patents are Expiring in the Next 10 Years?
The patent no. US8420650B2 which is expiring in Jul, 2029, describes changing in poly(ADP-ribose)polymerase (PARP) activity to treat or prevent diseases related to PARP. This involves giving a subject a therapeutic amount of compounds represented by Formula (I) and Formula (II), along with ionizing radiation, chemotherapy, or both.
Given below is the list of few drugs patented by Pfizer accompanied by a patent relevant to the drug which will be available for generic drug manufacturing and usage within the next/upcoming 10 years for treatment of various diseases and disorders.
| Drug Name | Patent Number | Patent Title | Patent Expiration |
| Talzenna | US8420650B2 | Dihydropyridophthalazinone Inhibitors… | Jul, 2029 |
| Toviaz | US7807715B2 | Pharmaceutical Compositions Compr… | Jun, 2027 |
| Vizimpro | US10596162B2 | Method For Treating Gefitinib… | Feb, 2026 |
| Vyndaqel | US7214696B2 | Compositions And Methods For… | Dec, 2024 |
| Nurtec Odt | US11083724B2 | Rimegepant For CGRP Related Dis… | Mar, 2039 |
Interested in knowing about Pfizer’s Drug Patents Expiring in the next 10 years?
How many Pfizer patents are Alive/Dead?
Worldwide Patents
How Many Patents did Pfizer File in Different Countries?
Countries in which Pfizer Filed Patents
| Country | Patents |
| United States of America | 5670 |
| Japan | 4617 |
| Europe (EPO) | 3973 |
| China | 2665 |
| Australia | 2544 |
| Mexico | 2499 |
| India | 2338 |
| Hong Kong (S.A.R.) | 2227 |
| Brazil | 2173 |
| Canada | 2169 |
| Korea (South) | 2067 |
| Taiwan | 1710 |
| Israel | 1703 |
| Singapore | 1594 |
| Spain | 1452 |
| South Africa | 1401 |
| Germany | 1334 |
| Austria | 1274 |
| Argentina | 1249 |
| Russia | 968 |
| New Zealand | 883 |
| Denmark | 849 |
| Indonesia | 823 |
| Malaysia | 792 |
| Norway | 718 |
| Chile | 717 |
| Portugal | 709 |
| Poland | 647 |
| Viet Nam | 614 |
| Peru | 604 |
| Philippines | 603 |
| Slovenia | 578 |
| Costa Rica | 559 |
| Africa | 559 |
| Eurasia | 489 |
| Colombia | 412 |
| Hungary | 409 |
| Tunisia | 355 |
| Ecuador | 341 |
| Serbia | 334 |
| Slovakia | 323 |
| Ukraine | 304 |
| Uruguay | 288 |
| Cyprus | 276 |
| Morocco | 275 |
| Estonia | 259 |
| Croatia | 249 |
| Mongolia | 218 |
| Macao | 217 |
| Turkey | 204 |
| Saudi Arabia | 201 |
| Dominican Republic | 200 |
| Thailand | 196 |
| Georgia | 191 |
| Panama | 180 |
| Italy | 175 |
| Cuba | 172 |
| Malta | 169 |
| Netherlands | 137 |
| Lithuania | 136 |
| Nicaragua | 120 |
| El Salvador | 118 |
| Uzbekistan | 110 |
| Gulf Cooperation Council | 96 |
| Yugoslavia/Serbia and Montenegro | 92 |
| Egypt | 90 |
| Albania | 84 |
| Iceland | 76 |
| Ireland | 74 |
| Finland | 73 |
| Pakistan | 71 |
| Czech Republic | 69 |
| Paraguay | 63 |
| Honduras | 61 |
| Republic Of Moldova | 60 |
| Montenegro | 58 |
| Brunei | 56 |
| Bolivia | 52 |
| Luxembourg | 48 |
| Guatemala | 45 |
| Bulgaria | 41 |
| Lebanon | 34 |
| Bangladesh | 33 |
| Kenya | 30 |
| United Kingdom | 19 |
| San Marino | 15 |
| Belgium | 14 |
| Former Yugoslav Republic of Macedonia | 11 |
| France | 11 |
| United Arab Emirates | 10 |
| Trinidad and Tobago | 9 |
| Romania | 8 |
| Rwanda | 6 |
| Algeria | 4 |
| Jordan | 3 |
| Switzerland | 3 |
| Kazakhstan | 2 |
| Belize | 1 |
| Latvia | 1 |
Where are Research Centres of Pfizer Patents Located?
10 Best Pfizer Patents
US7498298B2 is the most popular patent in the Pfizer portfolio. It has received 2698 citations so far from companies like Facet Biotech Corporation, Abbott and Genentech.
Below is the list of 10 most cited patents of Pfizer:
| Publication Number | Citation Count |
| US7498298B2 | 2698 |
| US7488802B2 | 2097 |
| US7108701B2 | 1770 |
| US7175843B2 | 1672 |
| US7232566B2 | 1666 |
| US7144575B2 | 1641 |
| WO2011143545A1 | 1326 |
| WO2012032433A1 | 870 |
| US7659241B2 | 849 |
| US7521051B2 | 716 |
What Percentage of Pfizer US Patent Applications were Granted?
Pfizer (Excluding its subsidiaries) has filed 5729 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2728 have been granted leading to a grant rate of 70.6%.
Below are the key stats of Apple patent prosecution at the USPTO.
Which Law Firms are managing US Patents for Pfizer?
| Law Firm | Total Applications | Success Rate |
| Pfizer (Inhouse IP Dept.) | 2336 | 64.92% |
| Gregg C Benson | 590 | 21.47% |
| Peter C Richardson | 504 | 94.47% |
| Paul H Ginsburg | 238 | 86.66% |
| Charles J Knuth | 168 | 87.20% |
| Haley Guiliano Llp | 121 | 81.14% |
| Zoetis | 111 | 87.27% |
| Scully Scott Murphy & Presser Pc | 81 | 68.07% |
| Johnson & Johnson | 80 | 71.43% |
EXCLUSIVE INSIGHTS COMING SOON!
What are Pfizer’s key innovation segments?
What Technologies are Covered by Pfizer?
The chart below distributes patents filed by Pfizer in different countries on the basis of the technology protected in patents. It also represents the markets where Pfizer thinks it’s important to protect particular technology inventions.
R&D Focus: How Pfizer search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
